跳至主要内容
临床试验/TCTR20150717001
TCTR20150717001已完成未知

Efficacy and Safety Profile of Autologous Blood Versus Talc Pleurodesis for Malignant Pleural Effusion

Human Research Ethic Committee0 个研究点目标入组 108 人开始时间: 2015年7月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • - Patients 18 years of age and older
  • - Symptomatic MPE (cytologically or histologically confirmed) patients
  • - Life expectancy of more than 3 months
  • - Good lung expansion after drainage of pleural fluid with approximation of visceral and parietal pleura
  • - Agreement to receive chemical pleurodesis for treatment of MPE

排除标准

  • - Any pleural or systemic infection
  • - Hemodynamic instability
  • - Hemothorax (pleural fluid over serum hematocrit > 50%)
  • - Serum hematocrit < 25%
  • - Chylothorax
  • - Combination of causes of pleural effusion
  • - History of talc or lidocaine allergy
  • - Chest X ray showing trapped lung after chest tube drainage
  • - Pregnancy

研究者

发起方
Human Research Ethic Committee

相似试验